Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Eurocommercial Properties in connection with the acquisition of Eurostop in Halmstad
Mandate

Vinge advises Eurocommercial Properties in connection with the acquisition of Eurostop in Halmstad

August 31, 2012

Vinge has advised Eurocommercial Properties in connection with the acquisition of Eurostop in Halmstad. The acquisition consists of two separate phases, i.e. a Coop Forum store of 10,800 m2 was acquired from Atrium Ljungberg and the integrated gallery of 13,600 m2 was acquired from Unibail-Rodamco. The integrated gallery has 31 units with several large tenants such as Willys, H&M, Lindex, Blomstelandet, Kappahl and Systembolaget. The gallery transaction also includes a hotel of 4,160 m2 as well as other smaller office and storage space. The total acquisition cost is MSEK 560.

Vinge’s team advising Eurocommercial Properties consisted of partner Patrick Forslund and, among others, associates Daniel Unger and Anna Lindner.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026